RARA CRAFT DATABASE for FDA Medical Devices
510(k)K171185

FDA DEVICE FACTS

IR Type Implant System

Biotem Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEDecember 1, 2017PRODUCT CODEDZE

Indications for use

IR Type Implant System is indicated for use in partially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including; cemented retained, screw retained, or overdenture restorations, and terminal or intermediate abutment support for fixed bridgework. IR Type Implant System is for one stage surgical procedures. It is intended for delayed loading. IR Implant System is intended only for straight placement with no correction of angulation. SS System is intended for use in partially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including; cemented retained, screw retained, or overdenture restorations, and terminal or intermediate abutment support for fixed bridgework. SS System is for one stage surgical procedures. It is not for immediate load. Design Internal Octa Tapered Internal Octa Tapered Material CP Ti Gr 4 ASTM F67 CP Ti Gr 4 ASTM F67 Sterilization Gamma sterilization Gamma sterilization Fixture Diameter (mm) Ø 3.5, 4.1, 4.8, 5.5 Ø 3.5-6.0 Fixture Length (mm) 7.5, 8.5, 10.0, 11.5, 13.0, 15.0 6.0-15.0

Abutment Diameters Ø 4.8. 6.0, 6.5 mm Ø 4.8, 6.0, 6.5 mm Lengths 2.0, 3.0, 4.0, 5.5 , 6.0 , 7.0mm 2.0, 4.0, 5.5, 7.0mm Angled 0° 20° Attachment Various abutments and components Various abutments and components Surface treatment RBM RBM Product Code DZE, NHA DZE, NHA 5 | P a g e Basis for Substantial Equivalence IR Type Implant System has a substantially equivalent intended use as the identified predicate (K062051). Both are used for mandible and maxilla endosseous dental implant and accessories. The IR Type Implant System is similar in fundamental scientific technology to the predicate device in that they all have been designed, manufactured and tested in compliance with FDA’s Class II special controls guidance document root-form endosseous dental implants and endosseous dental implant abutments. The subject and predicate devices are similar in size, surface treatment and materials. When compared with predicate devices, no new questions of substantially equivalence have been raised for the IR Type Implant System.

Non- Clinical Testing The subject device was tested to evaluate its performance as below.

• Sterilization Validation testing for sterile devices (fixtures) has been performed in accordance with ISO11137, ISO 11737-1& ISO 11737-2 for gamma sterilization

• Steam Sterilization validation for non-sterile devices (abutments) has been performed in accordance with ISO 17665-1 and IS 17665-2.

• Surface Characteristics Test Report - Chemical and SEM image analyses have been performed to verify that there is no residual after RBM treatment on the fixtures.

• Cytotoxicity Test performed according to ISO 10993-5:2009

• Sensitization test performed according to ISO 10993-10:2010

• LAL Endotoxin lot release testing according to USP <85>

• Shelf Life Testing performed according to ISO 11607

Those tests have been performed to evaluate the substantial equivalence in the surface characteristics compared to the predicate device. The result of the above tests have met the criteria of the standard, and proved the substantial equivalence with the predicate device. Non- clinical testing consisted of performance of testing in accordance with the FDA guidance "Class II Special Controls Guidance Document Root-form Endosseous Dental Implants and Endosseous Dental Implant Abutments." The results of the non-clinical testing demonstrate that the subject device is substantially equivalent to the predicate device

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026